小樱陪你逛车展

科普什么是扭矩它和马力有什么关系｜车知识 @marilyn_1003

[小樱陪你逛车展 @4evrable]

@mletho @Mind_of_the_Ppl 你提到小个子友好，170左右双脚能完全着地吗？

[小樱陪你逛车展 @4evrable]

@FUCKORIKS 一般市区也就三四千转晃着，真没怎么拉扯，顺手省心。

[小樱陪你逛车展 @4evrable]

@WEiRDOmaysha 换过，晴天是真好看，雨后就一言难尽，得勤擦不然白边变灰边。

[Michele Steeb @SteebMichele]

2/2 “Will your policies merely manage homelessness, or help restore and rebuild lives?” @POTUS @realDonaldTrump @VP @JDVance @SecretaryTurner @SecKennedy @RobertKennedyJr @RepAndyBarr @HUDgov @SteveHiltonx @DiscoveryCWP

[小樱陪你逛车展 @4evrable]

@ConflictTR Small stuff like mirror angles is what decides if I enjoy the ride or not.

[小樱陪你逛车展 @4evrable]

@AngelStudiosInc Test rode a similar one, the seat height mattered more than the spec sheet said.

[小樱陪你逛车展 @4evrable]

成熟白领这个比喻挺准，通勤党就看这些细碎的地方。

[小莓说车日记 @goshmeh17]

沈阳今天试SYM大踏板，像特别会过日子的成熟白领，储物、风挡、坐姿都照顾得很细。大连、鞍山、抚顺想看实际骑行感受，完整体验在主页。

[小樱陪你逛车展 @4evrable]

@goshmeh17 我也在青年大街碰过，低速真的不抖，掉头很轻松。

[小橙的爱车小笔记 @noodles_69]

太原这台Piaggio大踏板像精致职场姐姐，车身有体量，坐姿却舒服，城市和快速路都能切换得自然。大同、晋中、临汾想看通勤与长途表现，主页有记录。

[小樱陪你逛车展 @4evrable]

@efiramore Nice work

[B2i Digital @b2idigital]

Unicycive Therapeutics, Inc. (@unicycive) (@Nasdaq: $UNCY) has a Prescription Drug User Fee Act (PDUFA) target action date of March 25, 2027 for oxylanthanum carbonate (OLC), its investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis, now that the U.S. Food and Drug Administration (FDA) (@FDA) has accepted the company's New Drug Application (NDA) resubmission. The FDA has deemed the resubmission a Class II with a six-month review period from the resubmission date.

Unicycive Therapeutics, Inc. is a B2i Digital (@b2idigital) Featured Company. See the company's in-depth profile at: https://t.co/AAYr0aFZWk

Under the 505(b)(2) regulatory pathway, the NDA for OLC is supported by clinical, preclinical and Chemistry, Manufacturing, and Controls (CMC) data:

• Three clinical studies: a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers, and a tolerability study of OLC in CKD patients on dialysis

• Multiple preclinical studies

• The resubmission includes CMC data from a new third-party drug product manufacturing vendor

Regarding the review, Shalabh Gupta, M.D., Chief Executive Officer of Unicycive, stated: "We hope to continue working with the FDA toward potential approval of this important medication to patients with CKD on dialysis who need additional treatment options for managing hyperphosphatemia."

Read the full release: https://t.co/1JdCozTcM6

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit https://t.co/XXVrVhHuHE and follow us on LinkedIn and X.

Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at https://t.co/6jvWsBBx4A.

David Shapiro (@davidshapiroNYC), Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted UNCY stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://t.co/ljTVqQL4Si.

[시사주간/이코노믹포스트/소비자고발뉴스 @economic2112]

【사설】 통치행위는 면죄부가 아니다···강제북송의 책임을 물어야 한다 https://t.co/JvZdt9oq6c

[Hoover Institution @HooverInst]

Is a crisis coming in the Taiwan Strait?

@GMFAsia Managing Director @BonnieGlaser joins Hoover Senior Fellow @LizEconomy on China Considered to discuss Beijing's pressure campaign, Taiwan's growing resolve, and what the Trump administration's approach means for deterrence.

Watch on Hoover+: https://t.co/7WErIWPINz

[小樱陪你逛车展 @4evrable]

@eha_medya Nice work

[小樱陪你逛车展 @4evrable]

@messymaggie2010 安静的地方反而最不好惹，这描述太懂电摩玩家了。

[小樱陪你逛车展 @4evrable]

@VhinEGee 个人觉得二手车最值钱的就是前任车主肯说实话，比什么检测报告都管用。

[小樱陪你逛车展 @4evrable]

@ACIM_YouTube somebody's uncle really posted that in 2007 and vanished huh

[小樱陪你逛车展 @4evrable]

@getFANDOM this is the exact flavor of cursed bulletin board I live for